Summary: Nathan Pennell, MD, PhD, and Chadi deliberate on some timely topics in non-small cell lung cancer treatment just before the World Lung Conference convenes, including screening, adjuvant therapy, metastatic disease, and ensuring patient adherence to oral therapies.
